Please login to the form below
Eli Lilly begins COVID-19 prevention trial in nursing homes
Trial will investigate monoclonal antibody in up to 2,400 participants
AbbVie, Amgen and Takeda team up for joint COVID-19 trial
Collaborative trial will evaluate three anti-inflammatory drugs
Sanofi faces manslaughter allegations in France over Depakine deaths
Charges relate to deaths of four babies whose mothers took anti-epileptic drug during pregnancy
US secures 100 million doses of Sanofi/GSK’s COVID-19 vaccine
Both companies are also in talks with EU for access to candidate
UK will provide millions of 90-minute COVID-19 tests over the coming months
Tests will be rolled out ahead of the winter months
NeuroRx, Relief Therapeutics’ COVID-19 drug demonstrates early potential
Drug produced rapid recovery in critically-ill patients
J&J’s COVID-19 vaccine generates positive pre-clinical results
Experimental vaccine begins first-in-human trial this month
Roche’s Tecentriq combo scores FDA approval for melanoma
Drug approved for patients with BRAF protein mutations
Gilead’s top-line slips 10% as demand for HIV/hepatitis C drugs drops
Disruption to uptake of HIV and hepatitis C drugs caused by pandemic
Q&A: Kate Callan
-
Q&A: Kay WesleyPME chats to the Chief Executive of Kanga Health Ltd and Town Councillor at Women’s Equality Party Congleton
-
Q&A: Elizabeth EganElizabeth Egan is President of Havas Lynx Group
-
AstraZeneca escapes pandemic impact as new drugs bolster revenuesEarnings climbed above expectations in the second quarter
-
Roche pays $120m upfront for UCB’s anti-tau Alzheimer’s drugMilestone payments could reach up to $2bn
-
Boehringer/Lilly's Jardiance hits the mark in pivotal heart failure trialDrug reduced risk of death/hospitalisation in patients with and without diabetes
-
BMS/bluebird bio resubmit FDA application for myeloma CAR-TNovel CAR-T therapy targets heavily pre-treated myeloma
-
AZ strengthens Daiichi Sankyo partnership with new ADC dealDeal for experimental antibody drug conjugate could reach $6bn
-
Moderna looks to price COVID-19 vaccine at $50-$60 per courseShines spotlight on pricing strategies for potential vaccines
-
UK government and GSK/Sanofi sign COVID-19 vaccine supply dealUK adds to its arsenal of potential vaccine candidates
Latest appointments
-
New hires at EMA, Gilead and BeiGeneEMA gains a new executive director, Gilead appoints a new senior vice president and BeiGene hires a new chief business exec
-
New faces at HCA, P\S\L Group and Health UnlimitedNew board structure announced at HCA and a new MD appointed at Health Unlimited
-
W2O taps Tom Richards as creative leader of 21GRAMSRichards joins as co-global chief creative officer
-
McCann Health London bolsters creative leadership teamGuy Swimer and Kieran Delaney will lead the team
-
Syneos Health appoints trio of senior hiresIan Dorrian, JD Cassidy and Maria Tender bolster senior leadership team
COVID-19 Updates and Daily News
Featured jobs
- New study identifies drugs that are safe to use in COVID-19 treatment
- Boehringer/Lilly's Jardiance hits the mark in pivotal heart failure trial
- A new era for patient services?
- New data backs remdesivir for COVID-19, but rings hydroxychloroquine alarm bell
- Roche’s Tecentriq combo scores FDA approval for melanoma
- Moderna looks to price COVID-19 vaccine at $50-$60 per course
- Eli Lilly begins COVID-19 prevention trial in nursing homes
- AbbVie, Amgen and Takeda team up for joint COVID-19 trial
- Sanofi faces manslaughter allegations in France over Depakine deaths
- Introducing Porterhouse Intelligence Hub
- Medical Device Clinical Trials 2020
- Article: What's next? How behavioural science can support pharma's future
PMHub
OUTiCO
Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...
Latest intelligence
- Medical Device Clinical Trials 2020
- In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...
- Article: What's next? How behavioural science can support pharma's future
- ...
- Video: UX/ Experience design research
- ...
Quick links
Infographics
